title: IBD: Exposure to anti-TNF agents in utero: controlling health risks.
authors.affiliation: Erasmus University Medical Center, Department of Gastroenterology and Hepatology, Room HS 306, 's Gravendijkwal 230, Rotterdam 3015 CE, Netherlands.
authors.forename: C Janneke
authors.initials: CJ
authors.lastname: van der Woude
authors.affiliation: Erasmus University Medical Center, Department of Gastroenterology and Hepatology, Room HS 306, 's Gravendijkwal 230, Rotterdam 3015 CE, Netherlands.
authors.forename: Shannon L
authors.initials: SL
authors.lastname: Kanis
mesh_terms: D000068879:Adalimumab; D000911:Antibodies, Monoclonal; D006801:Humans; D015212:Inflammatory Bowel Diseases; D000069285:Infliximab; D014409:Tumor Necrosis Factor-alpha
chemical_list: D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab; D000068879:Adalimumab